[Causal therapy of multiple sclerosis].
Pöhlau
D
D
Neurologische Klinik, Ruhr-Universität am St.-Josef-Hospital, Bochum.
Rieks
M
M
Postert
T
T
Hoffmann
V
V
Przuntek
H
H
D006801:Humans; D007114:Immunization; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000628:therapy*; D004676:Myelin Basic Protein / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D004676:Myelin Basic Protein; D007372:Interferons
Kausale Therapie der multiplen Sklerose.